National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

yttrium Y 90 glass microspheres
An injectable formulation of yttrium Y 90 consisting of glass microspheres containing the radioisotope yttrium Y 90. When injected into the tumor vascular bed, yttrium Y 90 glass microspheres occlude tumor blood vessels and deliver a cytotoxic dose of beta radiation to the tumor site, thereby reducing the tumor burden. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:TheraSphere



Previous:yttrium Y 90 anti-CEA monoclonal antibody cT84.66, yttrium Y 90 daclizumab, yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A, yttrium Y 90 DOTA monoclonal antibody HuAFP31, yttrium Y 90 DOTA monoclonal antibody HuPAM4
Next:yttrium Y 90 humanized epratuzumab, yttrium Y 90 ibritumomab tiuxetan, yttrium Y 90 monoclonal antibody B3, yttrium Y 90 monoclonal antibody BrE-3, yttrium Y 90 monoclonal antibody Hu3S193

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov